Sanofi India

41
Sell
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE058A01010
  • NSEID: SANOFI
  • BSEID: 500674
INR
4,335.85
-35.85 (-0.82%)
BSENSE

Dec 05

BSE+NSE Vol: 50.47 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Sanofi India Cash flow Statement
Figures in Cr
Consolidated Cash Flow Results
Dec'24
Dec'23
No of Months
12
12
Profit Before Tax
562.00
845.00
Adjustment
25.00
-24.00
Changes In working Capital
-28.00
-349.00
Cash Flow after changes in Working Capital
558.00
471.00
Cash Flow from Operating Activities
461.00
230.00
Cash Flow from Investing Activities
-179.00
37.00
Cash Flow from Financing Activities
-392.00
-878.00
Net Cash Inflow / Outflow
-110.00
-610.00
Opening Cash & Cash Equivalents
394.00
1,004.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
Closing Cash & Cash Equivalent
283.00
394.00
Figures in INR Cr
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Sanofi India
Markets Mojo
Figures in Cr
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Profit Before Tax
562.4
102.86
460.00
446.76%
Adjustment
25.1
71.31
-46.00
-64.80%
Changes In working Capital
-28.6
-135.08
107.00
78.83%
Cash Flow after changes in Working Capital
558.9
39.08
519.00
1330.14%
Cash Flow from Operating Activities
461.5
21.01
440.00
2096.57%
Cash Flow from Investing Activities
-179.8
-68.38
-111.00
-162.94%
Cash Flow from Financing Activities
-392.4
43.55
-435.00
-1001.03%
Net Cash Inflow / Outflow
-110.7
-3.82
-107.00
-2797.91%
Opening Cash & Cash Equivalents
394.5
54.43
340.00
624.78%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
0
0.00
0.00%
Closing Cash & Cash Equivalent
283.8
50.61
233.00
460.76%
Cash Flow - Snapshot (Consolidated) - Dec'24
stock-summary

YoY Growth in year ended Dec 2024 is 100.30% vs NA in Dec 2023

Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
461.50
230.40
100.30%